Close

Articles Posted in Federal Preemption

Updated:

U.S. Court of Appeals Rules that State-Law Claims Are Not Barred Based on Doctrine of Field Pre-emption in Wrongful Death Aircraft Case

David Sikkelee was killed when a Cessna aircraft he was piloting crashed after taking off from North Carolina’s Transylvania County Airport. The plane had a Lycoming engine. In the lawsuit, his wife, Jill Sikkelee, alleged that the aircraft lost power due to defects in the design of the engine and…

Updated:

U.S. Court of Appeals Affirms Dismissal of Failure-to-Warn Claim for Generic Drug

This case was based on the distinction between brand name drugs and generics as decided by the U.S. Supreme Court in Wyeth v. Levine, 555 U.S. 555 (2009) and PLIVA v. Mensing, 564 U.S. 604 (2011).  The federal district court judge in Chicago, the Northern District of Illinois, dismissed failure-to-warn…

Updated:

U.S. District Court Judge Denies Motion of Dietary Supplement Company

Mary Ann Nichols of Chicago has filed a federal lawsuit against the dietary supplement company NaturMed Inc., which is also known as Institute for Vibrant Living. Her suit alleges that the company violated federal and state advertising laws. A federal judge decided against dismissing the class-action lawsuit against this company.…

Updated:

Federal Tort Claims Act Requires Written Notice to Federal Agency Before Lawsuit; LeGrande v. United States

Peggy LeGrande, who worked as a flight attendant for Southwest Airlines, was injured when the plane she working in encountered severe turbulence. She brought a lawsuit against the United States under the Federal Tort Claims Act (FTCA), 28 U.S.C. §2674, claiming that the air traffic controllers employed by the Federal…

Updated:

Generic Drug Companies Held to Lower Standard Than Name Brand Counterparts – U.S. Supreme Court Rules in Pliva v. Mensing

Federal preemption has long been a hot button issue in pharmaceutical drug cases, with consumer advocates arguing that drug companies should be held to the sometimes higher state standards. However, the U.S. Supreme Court appears to have reversed the federal preemption stance it took in Wyeth v. Levine. In Wyeth,…

Updated:

Mazda Seat Belt Case to go to Trial After Woman Dies – Williamson v. Mazda

The United States Supreme Court has ruled that a family is allowed to pursue its lawsuit in California against Mazda Motors of American, Inc. in the case of The Estate of Thanh Williamson v. Mazda, 08-1314. The product liability lawsuit deals with claims that the auto company’s 1993 Mazda MPV…

Updated:

Wyeth v. Levine Used to Reverse Pre-Emption of Chicago Pharmaceutical Litigation Case Against Glaxo Smith Kline (GSK)

An Illinois prescription drug case that originally had been dismissed due to issues of federal preemption, has been reinstated by the 7th Circuit Court of Appeals in Chicago. This case, Mason v. SmithKline Beecham Corp. d/b/a Glaxo SmithKline, No. 08-2265,___F.3d___, 2010 WL 605922 (7th Cir. Feb. 23, 2010) may be…

Updated:

Chicago’s John Marshall Law School Moot Court Team Practices at Kreisman Law Offices

The Moot Court Team of the John Marshall Law School of Chicago headed by Mary Nagel, their faculty sponsor, argued their moot court competition at Chicago’s Kreisman Law Offices before Civil Justice Attorney Robert Kreisman. Moot Court is an activity where law students participate in simulated appellate court proceedings. However,…

Updated:

Wyeth v. Levine: Supreme Court Overturns Pharmaceutical Litigation Preemption Claim

In its recent ruling the U.S. Supreme Court ruled that premarket approval from the Food & Drug Administration (FDA) does not preempt pharmaceutical companies from being held liable when their drug fails to meet state standards. In Wyeth v. Levine the court held that drug manufacturers can be sued in…

Updated:

Obama Transition Team Receives Complaints of “Corruption at the FDA”

Federal scientists associated with the Federal Food and Drug Administration (FDA), have written to the Obama transition team of widespread managerial misconduct within the medical device review department. The letter alleged that “the scientific review process for medical devices at the FDA has been corrupted and distorted by current FDA…

Contact Us